Bigger Data = Better Data: Detect 7,000 proteins at once with high throughput to optimize biomarker discovery

Abstract

The ideal biomarkers are waiting to be revealed within the human proteome. Big data from many thousands of protein analytes leads to superior biomarker models across therapeutic areas. In this webinar you will discover how machine learning can be harnessed to select the right targets and build the right models for your research. You will also learn how to develop models, identify and mediate clinical risk, and elevate your research with greater precision than ever.

Image of Joe Gogain, SomaLogic Director of Clinical R&D

Joe Gogain, PhD

Clinical R&D at SomaLogic

Joe Gogain is a Director of Clinical Research and Development at SomaLogic, Inc., where he works closely with collaborating partners developing diagnostic and prognostic proteomic applications. Joe is a biological scientist with molecular diagnostic and immunoassay development expertise. Joe has a proven track record of IVD product development under design control and experience in de novo 510(k) regulatory submission processes and requirements. Additionally, Joe has served as a director of national clinical trials for point-of-care diagnostic devices and has experience managing a variety of technicians, scientists and clinical operations personnel.

Bigger Data = Better Data: Detect 7,000 proteins at once with high throughput to optimize biomarker discovery

A webinar presented by Joe Gogain, PhD

Share with colleagues

More webinars

WebinarHuman proteomics: from the operating room to the lab and back

Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarker identification using proteomic tools. A series of studies using human eye fluids has helped to diagnose inflammatory retinal disease, select personalized therapies, stage cancer, and point to new therapeutic strategies. These approaches can be broadly applied to human surgical disease.

Learn more

Webinar10 things I hate about proteomics

Dr. Williams explains in a fun - but serious - way how proteomics is revolutionizing drug discovery research and precision medicine worldwide today. He also couldn't resist telling the story about what happens when two proteins walk into a bar.

Learn more

WebinarUsing plasma proteomics to understand diseases of the brain: alzheimer’s & cerebral small vessel disease

This presentation will demonstrate how proteins measured in blood decades before dementia onset can be combined with genetic data to (1) identify novel early biomarkers for Dementia, Alzheimer’s disease, and brain MRI characteristics indicative of Cerebral Small Vessel disease, and (2) better understand the molecular pathways altered in the preclinical and prodromal phase of neurodegenerative disease.

Learn more

Explore webinars in our interactive viewer